drugset / Trial / NCT00105287
Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and tolerability of OraVescent fentanyl when used long-term to relieve breakthrough pain in opioid tolerant cancer patients.
Timeline
- Start
- 2005-01
- Primary completion
- 2006-09
- Completion
- 2007-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fentanyl | Other / unclassified | — | — |